Literature DB >> 26136420

Control of Macrophage Dynamics as a Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation.

Wakana Ohashi1, Kohshi Hattori1, Yuichi Hattori2.   

Abstract

Macrophages are a well recognized player of both innate and adaptive immunity and have emerged as a key regulator of systemicmetabolism, hematopoiesis, vasculogenesis, apoptosis, malignancy, and reproduction. Such pleiotropic roles of macrophages are mirrored by their protean features. Upon environmental. challenges, macrophages redistribute and differentiate in situ and contribute to the multiple disease states by exerting protective and pathogenic effects. The environmental challenges include cytokines, chemokines, lipid mediators, and extrinsic insults, such as food and pathogenic bacteria. In addition, homeostasis and the activation state of macrophages are influenced by various metabolites from a commensal microbe that colonizes epithelial and mucosal surfaces, such as the lungs, intestines, and skin. In this review, we describe macrophage differentiation, polarization, and various functions in chronic disease states, including chronic inflammatory bowel disease, tumorigenesis, metabolism and obesity, and central nervous system demyelinating disorders. Controlling the macrophage dynamics to affect the pathologic states is considered to be an important therapeutic approach for many clinical disorders involving chronic inflammation.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Year:  2015        PMID: 26136420     DOI: 10.1124/jpet.115.225540

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Oral NaHCO3 Activates a Splenic Anti-Inflammatory Pathway: Evidence That Cholinergic Signals Are Transmitted via Mesothelial Cells.

Authors:  Sarah C Ray; Babak Baban; Matthew A Tucker; Alec J Seaton; Kyu Chul Chang; Elinor C Mannon; Jingping Sun; Bansari Patel; Katie Wilson; Jacqueline B Musall; Hiram Ocasio; Debra Irsik; Jessica A Filosa; Jennifer C Sullivan; Brendan Marshall; Ryan A Harris; Paul M O'Connor
Journal:  J Immunol       Date:  2018-04-16       Impact factor: 5.422

2.  Impact of a long-term high-glucose environment on pro-inflammatory responses in macrophages stimulated with lipopolysaccharide.

Authors:  Tokiko Suzuki; Shigeyuki Yamashita; Kohshi Hattori; Naoyuki Matsuda; Yuichi Hattori
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-08-17       Impact factor: 3.000

Review 3.  Cystic Fibrosis Lung Immunity: The Role of the Macrophage.

Authors:  Emanuela M Bruscia; Tracey L Bonfield
Journal:  J Innate Immun       Date:  2016-06-24       Impact factor: 7.349

4.  Comparative Analysis of the Effects of Two Probiotic Bacterial Strains on Metabolism and Innate Immunity in the RAW 264.7 Murine Macrophage Cell Line.

Authors:  Biswaranjan Pradhan; Dipanjan Guha; Pratikshya Ray; Debashmita Das; Palok Aich
Journal:  Probiotics Antimicrob Proteins       Date:  2016-06       Impact factor: 4.609

5.  Effects of IRF1 and IFN-β interaction on the M1 polarization of macrophages and its antitumor function.

Authors:  Changli Xie; Cuiying Liu; Bitao Wu; Yan Lin; Tingting Ma; Haiyu Xiong; Qin Wang; Ziwei Li; Chenyu Ma; Zhiguang Tu
Journal:  Int J Mol Med       Date:  2016-05-10       Impact factor: 4.101

6.  The anti-inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell line.

Authors:  Linda Gabrielsson; Sandra Gouveia-Figueira; Jenny Häggström; Mireille Alhouayek; Christopher J Fowler
Journal:  Pharmacol Res Perspect       Date:  2017-02-27

Review 7.  Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?

Authors:  Luca Parisi; Elisabetta Gini; Denisa Baci; Marco Tremolati; Matteo Fanuli; Barbara Bassani; Giampietro Farronato; Antonino Bruno; Lorenzo Mortara
Journal:  J Immunol Res       Date:  2018-01-14       Impact factor: 4.818

8.  The Mincle ligand trehalose dibehenate differentially modulates M1-like and M2-like macrophage phenotype and function via Syk signaling.

Authors:  Kristel Kodar; Jacquie L Harper; Melanie J McConnell; Mattie S M Timmer; Bridget L Stocker
Journal:  Immun Inflamm Dis       Date:  2017-07-19

Review 9.  Chemopreventive Effects of Phytochemicals and Medicines on M1/M2 Polarized Macrophage Role in Inflammation-Related Diseases.

Authors:  Yen-Chun Koh; Guliang Yang; Ching-Shu Lai; Monthana Weerawatanakorn; Min-Hsiung Pan
Journal:  Int J Mol Sci       Date:  2018-07-28       Impact factor: 5.923

10.  Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophages.

Authors:  Asuka Yasueda; Hisako Kayama; Michiko Murohashi; Junichi Nishimura; Koji Wakame; Ken-Ichi Komatsu; Takayuki Ogino; Norikatsu Miyoshi; Hidekazu Takahashi; Mamoru Uemura; Chu Matsuda; Toru Kitagawa; Kiyoshi Takeda; Toshinori Ito; Yuichiro Doki; Hidetoshi Eguchi; Shigeomi Shimizu; Tsunekazu Mizushima
Journal:  Sci Rep       Date:  2020-06-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.